Cancer Resources
-
Core Mission: Cure blood cancers such as leukemia, lymphoma, Hodgkin’s disease, and myeloma—and improve life quality for affected individuals and families.
Three-Pronged Approach:
Fund and drive transformative research.
Deliver front-line patient support, education, and access.
Advocate for equitable, effective policy and systemic change.
Long-Term Vision: Extend and enhance lives—measured in meaningful milestones—while building toward a cancer-free future by 2040.
Donate to bloodcanceruntied.org
-
Mission Statement
Stand Up To Cancer’s mission is to raise awareness and fund research to detect and treat cancers, with the aspiration to cure all patients.
Strategic Goals & Vision
Early Detection as Standard of Care:
SU2C aims to make early-stage cancer detection a routine part of medical care, targeting a 25% reduction in cancer deaths within five years and 50% within ten years.Transformative Research Approach:
SU2C funds “translational research”—where discoveries move rapidly from lab to patient—through innovative structures like Dream Teams, Catalyst® Teams, and Convergence Research Teams. These models encourage interdisciplinary collaboration among academic and industry scientists to accelerate breakthroughs.Collaboration Across Sectors:
SU2C harnesses the power of the entertainment and media industries to engage the public, raise funds, and amplify awareness, leveraging celebrity-driven campaigns and televised events.
In Short
Stand Up To Cancer is not just a fundraising organization—it’s a movement that blends scientific innovation, public engagement, and strategic collaboration to transform cancer care. Through groundbreaking research models, celebrity-fueled campaigns, and a bold vision for the future, SU2C works toward a world where every cancer is caught early and cured, and every patient can live fear-free.
Donate to StandUpToCancer
-
Key Focus Areas
While “We save lives through cell therapy” is succinct, here’s how NMDP brings that mission to life:
Expanding the Reach of Cell Therapy
NMDP operates as a global nonprofit leader in cell therapy, extending beyond marrow to a wide spectrum of treatments. NMDP+1Promoting Equity and Accessibility
Through initiatives like Donor for All, NMDP is actively working to improve access to transplants for ethnically diverse patients, striving to eliminate barriers rooted in genetics or socio-economic factors.
In Summary
Mission: We save lives through cell therapy.
Vision: A world where every patient can receive life-saving cell therapy.
Strategy: Leading cell therapy efforts globally, innovating access, and addressing disparities to ensure equitable outcomes for all.
Be the Match: Sign Up Here
-
The mission of the American Red Cross is to prevent and alleviate human suffering in the face of emergencies by mobilizing the power of volunteers and the generosity of donors.
They deliver this mission by providing disaster relief, supporting military families, supplying lifesaving blood, offering health and safety training, and engaging in international humanitarian work guided by the principles of humanity, impartiality, neutrality, independence, voluntary service, unity, and universality.Give Blood - Sign up Here
-
By 2050, the United States is projected to experience a significant increase in cancer cases, primarily due to an aging population and demographic shifts. According to estimates from the Centers for Disease Control and Prevention (CDC), the annual number of new cancer cases is expected to rise by approximately 49%, from about 1.5 million in 2015 to over 2.2 million in 2050.
This surge is anticipated to be most pronounced among older adults. For instance, individuals aged 65 and older are projected to account for about 63% of all new cancer cases in 2050, up from 55% in 2015. This demographic shift underscores the need for healthcare systems to adapt to the growing demands of an aging population.
The most significant increases in cancer cases are expected in cancers such as female breast, prostate, colon and rectum, and melanoma of the skin. These four cancer types are projected to account for nearly half of all new cancer cases in 2050.